Patent Number: 7,132,243

Title: Clonal expansion of T cells of unknown specificity and identification of ligand recognized by the clonally expanded T cells

Abstract: A process for clonally expanding T cells of unknown specificity and a process for identifying a peptide ligand recognized by said T cells are provided. A process for clonally expanding T cells of unknown specificity which comprises co-culturing said T cells of unknown specificity with combinatorial randomized peptide library (Xn peptide library wherein n is a number of amino acids) consisted of peptides having a randomized amino acid sequence consisted of amino acid residues selected from nineteen kinds of naturally occurring amino acid other than cysteine, an interleukin, and major histocompatibility complex (MHC) class II antigen-expressing cells with DNA synthesis being suspended, said cells being derived from the individual where said T cells are obtained; and a process for identifying a peptide ligand recognized by the T cell clone of unknown specificity obtained by said process, which comprises determining proliferating activity of said T cell clone with Xn peptide library, in the presence of an interleukin and MHC class II antigen-expressing cells with DNA synthesis being suspended, said cells being derived from the individual where said T cells are obtained, to thereby determine a peptide sequence that can activate proliferation of T cells.

Inventors: Matsushita; Sho (Kumamoto, JP), Nakashima; Toshihiro (Kumamoto-ken, JP)

Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute

International Classification: G01N 33/53 (20060101); C12N 5/08 (20060101); G01N 33/566 (20060101); C40B 40/10 (20060101)

Expiration Date: 2019-11-07 0:00:00